The aim of the present study was to provide an
intercalator-based photogenotoxicity (
IBP) assay as a high-throughput in vitro screening system for predicting the photogenotoxic potential of pharmaceutical substances. The conditions of the high-throughput
IBP assay using
thiazole orange (TO), a fluorescent intercalating
dye, were optimized and validated by a fluorescence titration experiment and reproducibility/robustness test. The
IBP assay was applied to 27 phototoxic and 5 weak/non-phototoxic commercially available compounds, and other
phototoxicity screenings were also carried out for comparison; these included the
reactive oxygen species (ROS) assay for overall phototoxic potential and the
DNA-photocleavage assay for photogenotoxic risk. According to the results from the comparative experiments, a decreased level of intercalated TO in the
IBP assay could theoretically be related to the
DNA-photocleaving behaviors of phototoxic drugs, but not to their ROS-generating abilities. The
IBP assay could predict the photodynamic
DNA impairment caused by irradiated drugs with a prediction accuracy of 78%. These findings suggest that the
IBP assay could be a fast and reliable tool for predicting the photogenotoxic potential of a large number of drug candidates at early stages of drug discovery.